{"url":"https://lda.senate.gov/api/v1/filings/6f5abb99-e7f4-4e0a-b664-69fce38d5ed8/","filing_uuid":"6f5abb99-e7f4-4e0a-b664-69fce38d5ed8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2014,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/6f5abb99-e7f4-4e0a-b664-69fce38d5ed8/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Richard M. Gold, Partner","dt_posted":"2014-04-18T14:21:40.180000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 17th Street, N.W., Suite 1100","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":18466,"url":"https://lda.senate.gov/api/v1/registrants/18466/","house_registrant_id":30825,"name":"HOLLAND & KNIGHT LLP","description":"Law Firm","address_1":"800 17th Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RICHARD GOLD","contact_telephone":"+1 202-955-3000","dt_updated":"2026-01-29T12:53:12.839213-05:00"},"client":{"id":125411,"url":"https://lda.senate.gov/api/v1/clients/125411/","client_id":1007693,"name":"ACTAVIS, INC.","general_description":"Pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-02-18"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Advocate regarding provisions of patent reform legislation:  S.1720, Patient Transparency & Improvement Act; S.1013, Patient Abuse Reduction Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47502,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"WERNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58565,"prefix":"mr","prefix_display":"MR.","first_name":"PAUL","nickname":null,"middle_name":"S.","last_name":"BOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}